Literature DB >> 14599616

Can a practicing surgeon detect early lymphedema reliably?

Keiva L Bland1, Rebecca Perczyk, Wei Du, Christine Rymal, Prathima Koppolu, Ruthie McCrary, Kathryn A Carolin, Mary Ann Kosir.   

Abstract

BACKGROUND: Lymphedema may be identified by simpler circumference changes as compared with changes in limb volume.
METHODS: Ninety breast cancer patients were prospectively enrolled in an academic trial, and seven upper extremity circumferences were measured quarterly for 3 years. A 10% volume increase or greater than 1 cm increase in arm circumference identified lymphedema with verification by a lymphedema specialist. Sensitivity and specificity of several different criteria for detecting lymphedema were compared using the academic trial as the standard.
RESULTS: Thirty-nine cases of lymphedema were identified by the academic trial. Using a 10% increase in circumference at two sites as the criterion, half the lymphedema cases were detected (sensitivity 37%). When using a 10% increase in circumference at any site, 74.4% of cases were detected (sensitivity 49%). Detection by a 5% increase in circumference at any site was 91% sensitive.
CONCLUSIONS: An increase of 5% in circumference measurements identified the most potential lymphedema cases compared with an academic trial.

Entities:  

Mesh:

Year:  2003        PMID: 14599616     DOI: 10.1016/j.amjsurg.2003.07.003

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

1.  Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care.

Authors:  Nicole L Stout; Lucinda A Pfalzer; Barbara Springer; Ellen Levy; Charles L McGarvey; Jerome V Danoff; Lynn H Gerber; Peter W Soballe
Journal:  Phys Ther       Date:  2011-09-15

2.  A qualitative assessment of upper quarter dysfunction reported by physical therapists treated for breast cancer or treating breast cancer sequelae.

Authors:  Pamela K Levangie; Anita M Santasier; Nicole L Stout; Lucinda Pfalzer
Journal:  Support Care Cancer       Date:  2010-07-22       Impact factor: 3.603

3.  Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients.

Authors:  Igor Langer; Ulrich Guller; Gilles Berclaz; Ossi R Koechli; Gabriel Schaer; Mathias K Fehr; Thomas Hess; Daniel Oertli; Lucio Bronz; Beate Schnarwyler; Edward Wight; Urs Uehlinger; Eduard Infanger; Daniel Burger; Markus Zuber
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

4.  Comparison of breast cancer-related lymphedema (upper limb swelling) prevalence estimated using objective and subjective criteria and relationship with quality of life.

Authors:  Catherine Bulley; Susanne Gaal; Fiona Coutts; Christine Blyth; Wilma Jack; Udi Chetty; Matthew Barber; Chee-Wee Tan
Journal:  Biomed Res Int       Date:  2013-06-18       Impact factor: 3.411

5.  Diagnosis of Upper-Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of APTA.

Authors:  Kimberly Levenhagen; Claire Davies; Marisa Perdomo; Kathryn Ryans; Laura Gilchrist
Journal:  Rehabil Oncol       Date:  2017-06-30

Review 6.  Diagnosis of Upper Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of the American Physical Therapy Association.

Authors:  Kimberly Levenhagen; Claire Davies; Marisa Perdomo; Kathryn Ryans; Laura Gilchrist
Journal:  Phys Ther       Date:  2017-07-01

7.  Early surveillance is associated with less incidence and severity of breast cancer-related lymphedema compared with a traditional referral model of care.

Authors:  Louise A Koelmeyer; Robert J Borotkanics; Jessica Alcorso; Philip Prah; Caleb J Winch; Kristine Nakhel; Catherine M Dean; John Boyages
Journal:  Cancer       Date:  2018-12-06       Impact factor: 6.860

8.  Acupuncture in the treatment of upper-limb lymphedema: results of a pilot study.

Authors:  Barrie R Cassileth; Kimberly J Van Zee; K Simon Yeung; Marci I Coleton; Sara Cohen; Yi H Chan; Andrew J Vickers; Daniel D Sjoberg; Clifford A Hudis
Journal:  Cancer       Date:  2013-04-10       Impact factor: 6.860

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.